Trade BFRI stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Biofrontera Inc. (BFRI) is trading at US$1.54, down 1.28% today as of Sep 9, 16:00 EDT. The company has a market capitalisation of US$21.98M. Over the past 52 weeks, BFRI has traded between US$0.55 and US$1.66. On Syfe you can trade BFRI with $0 commission and add it to your watchlist.
| Previous close | US$1.56 |
|---|---|
| Market cap | US$21.98M |
| P/E ratio | 88.80 |
| 52-week range | US$0.55 – US$1.66 |
| Volume | 527.21K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Biofrontera Inc.
Biofrontera, Inc. is a biopharmaceutical company, which engages in the commercialization of pharmaceutical products. It specializes in the treatment of dermatological conditions, caused primarily by exposure to sunlight that results in sun damage to the skin. The company focuses on the treatment of actinic keratosis and markets a topical antibiotic for treatment of impetigo. Its products include Ameluz and Xepi, its two prescription drugs, and BF-RhodoLED, a lamp used with Ameluz, for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company was founded on March 3, 2015 and is headquartered in Woburn, MA.
Year: 2021
--Benchmark Downgrades Biofrontera to Speculative Buy From Buy, Price Target is $3
May 19, 10:28 AM · MT Newswires
Biofrontera Inc. (BFRI) stock is trading at US$1.54, -1.28% from the previous close of US$1.56.
The market cap for Biofrontera Inc. (BFRI) stock is approximately US$21.98M.
The price-to-earnings ratio for Biofrontera Inc. (BFRI) is 88.80, based on the latest reported earnings.
The 52-week high for Biofrontera Inc. (BFRI) stock is US$1.66.
The 52-week low for Biofrontera Inc. (BFRI) stock is US$0.55.
Biofrontera Inc. (BFRI) does not currently pay a dividend.
Stay on top of BFRI
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
